Online first
Clinical vignette
Published online: 2024-01-31

open access

Page views 241
Article views/downloads 82
Get Citation

Connect on Social Media

Connect on Social Media

Trichomegaly as a rare complication of panitumumab therapy for colon cancer

Jakub Krzysztof Gałązka1, Katarzyna Szklener2, Paweł Polski3, Mariusz Matuszek3, Sławomir Mańdziuk2


Not available

Article available in PDF format

View PDF Download PDF file


  1. Agirgol S, Çaytemel C, Pilanci KN. Dermatological side effects of targeted antineoplastic therapies: a prospective study. Cutan Ocul Toxicol. 2020; 39(4): 380–384.
  2. Lacouture ME, Maitland ML, Segaert S, et al. A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Support Care Cancer. 2010; 18(4): 509–522.
  3. Ragin D, Basałygo M, Nowacka K, et al. Cutaneous adverse reactions during epidermal growth factor receptor inhibitor therapy. Przegl Dermatol. 2018; 105: 421–433.